ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 2035

$881K Total Retail Price of All Prescriptions

Rank: 66 out of 2035

416 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 13,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 810 750 1 7
LEVOTHYROXINE SODIUM 681 621 2 4
OMEPRAZOLE 546 484 3 5
HYDROCODONE-ACETAMINOPHEN 523 454 S3 4 2
METOPROLOL TARTRATE 450 426 5 8
DONEPEZIL HCL 431 431 6 24
LISINOPRIL 427 394 7 3
POLYETHYLENE GLYCOL 3350 418 394 8 48
GABAPENTIN 415 343 9 14
METOPROLOL SUCCINATE 383 378 10 16
FENTANYL 354 319 S2 11 53
SIMVASTATIN 307 246 12 1
SERTRALINE HCL 277 259 13 23
NAMENDA 254 241 14 37
LANTUS 234 197 15 40
RISPERIDONE 227 216 16 68
ESCITALOPRAM OXALATE 227 217 16 77
ALBUTEROL SULFATE 217 206 18 90
WARFARIN SODIUM 216 198 19 11
CITALOPRAM HBR 211 173 20 20
CYMBALTA 201 166 21 59
LEVETIRACETAM 197 183 22 87
POTASSIUM CHLORIDE 190 172 23 18
NOVOLOG 179 160 24 95
DIVALPROEX SODIUM 172 149 25 75
MIRTAZAPINE 145 137 26 46
QUETIAPINE FUMARATE 141 123 27 70
AMLODIPINE BESYLATE 138 135 28 6
PAROXETINE HCL 136 119 29 69
TRAMADOL HCL 122 105 30 19
NYSTATIN 121 89 31 103
ALLOPURINOL 119 119 32 34
CARBIDOPA-LEVODOPA 114 89 33 94
ISOSORBIDE MONONITRATE ER 113 105 34 32
NYSTOP 113 101 34 150
LEVEMIR 108 105 36 236
MORPHINE SULFATE ER 108 107 S2 36 86
IPRATROPIUM-ALBUTEROL 103 91 38 146
KLOR-CON M20 101 79 39 73
PREDNISONE 92 50 40 36
ATENOLOL 91 90 41 10
CARVEDILOL 87 80 42 22
RANITIDINE HCL 87 87 42 28
LOSARTAN POTASSIUM 86 86 44 15
CIPROFLOXACIN HCL 80 65 45 63
TRANSDERM-SCOP 79 71 46 271
FAMOTIDINE 77 76 47 71
METOLAZONE 72 60 48 162
TRAZODONE HCL 70 42 49 50
MORPHINE SULFATE 69 63 S2 50 183
VENLAFAXINE HCL ER 68 63 51 130
FLUTICASONE PROPIONATE 68 54 51 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 61 53 110
PRAVASTATIN SODIUM 65 60 54 17
ADVAIR DISKUS 65 61 54 38
OXYBUTYNIN CHLORIDE ER 65 41 54 117
OXYCODONE HCL 63 48 S2 57 62
ATORVASTATIN CALCIUM 62 57 58 13
BACLOFEN 62 42 58 112
PANTOPRAZOLE SODIUM 59 44 60 42
MELOXICAM 59 49 60 56
TAMSULOSIN HCL 57 55 62 25
PLAVIX 57 55 62 49
ROPINIROLE HCL 55 55 64 113
DIOVAN 55 43 64 76
METFORMIN HCL 55 43 64 9
DILTIAZEM 24HR CD 55 48 64 122
CLOPIDOGREL 54 51 68 30
LIDODERM 54 50 68 72
ABILIFY 53 38 70 174
SINGULAIR 53 48 70 119
DIGOXIN 52 40 72 67
LEVOFLOXACIN 50 49 73 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.